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Evidence-based speech, 
language and hearing 
therapy and the Cochrane 
Library’s systematic reviews
With hundreds of health studies being published every 
month, we felt there was a need to produce a synthesis of the 
information that is relevant to our field of knowledge. There 
is also a need for high-quality articles to act as guidelines for 
clinical practice.1
This is one of the objectives of evidence-based medicine, 
which is an approach that uses the tools of clinical epidemiol-
ogy, scientific methodology and computer science to examine 
the existing information, create research results and gener-
ate useful knowledge of health-related issues. Through this, 
consistent evidence for health-related decision-making can 
be put forward.2
Thus, evidence-based medicine is a link between good 
scientific research and clinical practice. Through clinical epide-
miology, strict methods for study design and the preparation, 
planning, execution and statistical analysis of scientific projects 
are obtained. In order to obtain reliable evidence and be able 
to use evidence-based medicine, health professionals must 
carry out efficient literature searches and select relevant and 
methodologically appropriate studies.2
Therefore, ideally, the practice of evidence-based medicine 
should be a systematic process that includes various phases: 
formulation of a relevant clinical question based on the patients’ 
clinical status, literature search for relevant clinical articles, 
critical analysis of the validity and applicability of the evidence 
(scientific proof ), and lastly, transfer of the important findings 
to clinical practice.2
Evidence-based health is another term in current use among 
professional groups that already carry out critical evaluation 
of the literature, in fields like cardiology, psychiatry, gynecol-
ogy, physiotherapy and other branches of medicine. Within 
this context, it is also appropriate and necessary to develop 
evidence-based speech, language and hearing therapy, with 
the aim of using the same tools as in evidence-based medicine. 
Through this, we can explore therapeutic issues that gained 
approval on the basis of poor data (resulting from the scientific 
methodology employed).
When we speak of the evidence favoring a type of treat-
ment, we consider its effectiveness, efficiency, efficacy and 
safety. Its effectiveness is an assessment of how well it works 
under real-world conditions. It efficacy is how well it works 
under ideal conditions. Its efficiency is a measurement of how 
inexpensive and accessible it is, so that users can have recourse 
to it. And lastly, its safety is an evaluation of whether the 
intervention is reliable and does not lead to effects that the 
patient does not desire.2
Therefore, a study that is both internally and externally 
valid must present the characteristics described above. When 
researching information on interventions or prevention, we seek 
studies that best fit this mold, which means systematic reviews 
that offer level 1 evidence for healthcare decision-making.2 
Systematic reviews are thus a type of secondary study. That 
is to say, they include primary studies (randomized clinical 
trials) that are methodologically appropriate and stringent, 
and potentially bias-free. Their purpose is to bring together 
and organize similar studies, to evaluate their methodology, 
and, where possible, include them in a meta-analysis.2
Meta-analysis is a statistical technique in which all 
the data from all the available studies on some topic are 
combined. The technique is used by researchers to get a 
maximum of statistical information without worrying about 
distortions in the results.2
In dealing with speech, language and hearing therapy, 
we also feel there is a need to organize the existing informa-
tion in this field, and thus provide adequate guidelines for 
therapeutic methods.
The most sensible way of answering our everyday queries 
is to seek help from sources of evidence-based medicine. The 
best of these sources is the Cochrane Library, which maps 
clinical trials according to their methods and combines them 
when appropriate, based on meta-analysis methodology. This 
virtual library is considered one of the best sources of evidence 
for healthcare decision-making. It assembles eight data banks, 
including the database of systematic reviews and meta-analyses, 
abstracts of reviews of effects, Cochrane controlled trials register 
(CENTRAL), methodology reviews, economic evaluation and 
health technology evaluation.
A review of the literature conducted in the Cochrane 
Library’s database of systematic reviews (issue 1, 2006) on the 
practices of speech, language and hearing therapy identified 
15 systematic reviews and protocols for the terms “dyspha-
gia”, “dysarthria”, “speech and language therapy”, “aphasia”, 
“voice disorders”, “audiology”, “audiometry”, “hearing loss”, 
“myofunctional therapy” and their respective synonyms. These 
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terms, which are specific to speech, language 
and hearing therapy, were combined using 
Boolean operators (and, or, and not) in order 
to narrow the search. 
As mentioned, there are 15 reviews and 
protocols relating to the field of speech, 
language and hearing therapy. If we consider 
that there are 2,180 systematic reviews in 
this database, which cover various healthcare 
topics, it is clear that speech, language and 
hearing therapy has a long road to run if it 
is to answer 50% of the questions posed in 
this field. We do, however, already have a few 
studies presenting level 1 evidence, on which 
to build clinical practice.
We shall now briefly describe the Co-
chrane systematic reviews relating to the 
practices of speech, language and hearing 
therapy. One of the systematic reviews had the 
aim of establishing the effects of nutritional 
supplementation through gastrostomy or 
jejunostomy, in comparison with oral feed-
ing alone, in children with cerebral palsy and 
a diagnosed eating disorder. No controlled 
clinical trials were found that met the inclu-
sion criteria for systematic reviews, so there 
is thus no good evidence available at the mo-
ment that allows us to conclude that enteral 
or stomach feeding can be either beneficial or 
harmful, in comparison with a control group. 
We therefore recommend that well-designed 
clinical trials should be conducted in order to 
verify whether nutritional supplementation 
has any effect as an alternative for children 
with eating disorders.3
It is unclear how dysphagic patients should 
be treated and fed after a cerebrovascular ac-
cident. Bath and Bath (2000) conducted a 
systematic review that had the objective of ana-
lyzing strategies to be used among dysphagic 
patients, with particular attention devoted to 
when and how to feed them. Only two studies 
with small samples were included. Among the 
implications for clinical practice, percutane-
ous gastrostomy may increase the nutritional 
outcome, in comparison with nasogastric 
tubing in dysphagic patients. However, more 
research is needed in order to know when and 
how to feed these patients, and also to analyze 
the effects of language therapy and medication 
therapy on dysphagia.4 
Dysphagia is a common complication in 
progressive muscle disorders, both in adults 
and children, and one that is currently not 
properly understood. Hill et al. (2004) de-
termined the most appropriate intervention 
for patients with muscle disorders, including 
consideration of randomized and quasi-ran-
domized clinical trials. No study that met 
the inclusion criteria was found. It was thus 
impossible to determine what the best inter-
vention for treating dysphagia was.5
Deane et al. (2001) compared the efficacy 
and effectiveness of non-pharmacological 
therapy with placebo or no intervention 
in patients with Parkinson’s disease with 
dysphagia. No controlled clinical trial was 
found that met the inclusion criteria. There 
was therefore no evidence that supports the 
efficacy of this therapy. It was suggested that 
rigorously planned controlled clinical trials 
should be conducted.6 
After searching through the Cochrane 
systematic reviews, we found one review pro-
tocol, i.e. one ongoing systematic review that 
was designed to compare the efficacy of dif-
ferent interventions in dysphagic patients with 
esophageal cancer. As this is only a protocol, 
the authors are still in the process of extracting 
and analyzing the data.7
Aphasia can be defined as language impair-
ment due to a brain lesion. With regard to its 
treatment, Greener et al. (2000) established 
that speech and language therapy supplied by a 
qualified professional was effective, in compari-
son with informal therapy, i.e. therapy supplied 
by someone who is not formally trained or 
qualified in this field. The controlled clinical 
trials identified were not methodologically 
robust enough to allow a conclusion regard-
ing whether intervention is more effective in 
aphasic patients than in control groups.8 
Likewise, we retrieved a systematic 
review that evaluated the efficacy of speech 
and language therapy in adult patients with 
dysarthria. Dysarthria is the condition of 
difficulty in speech articulation (abnor-
malities in the neuromuscular control of 
palate, tongue and lip movements). Sellars 
et al. (2005) concluded that there was not 
enough evidence to answer this question. In 
other words, there were no methodologically 
sound studies that could be included in the 
systematic review. The authors ended by 
stating that there was a fundamental need 
for high-quality research in this field.9
Deane et al. (2001) reviewed treatments 
for patients with dysarthria, using Parkinson’s 
disease as the clinical situation, speech and 
language therapy as the intervention, pla-
cebo for the control group, and the ability to 
communicate with intelligible speech as the 
clinical outcome. Three randomized clinical 
trials were included, with a total of 63 pa-
tients. Considering the limited sample size, 
the inadequate methodology of the clinical 
trials, and the possibility of publication bias, 
there was insufficient evidence to establish 
whether language and speech therapy among 
dysarthric patients is efficacious. The authors 
suggested that more controlled clinical trials 
with larger numbers of participants should 
be conducted.10
Deane et al. (2001) also carried out an-
other systematic review with the aim of com-
paring the use of different speech and language 
therapy techniques with the same population. 
They came to the same conclusion as in the 
previous revision: there was not enough evi-
dence to answer the clinical question.11
Law et al. (2003) aimed to determine 
the effectiveness of speech therapy in chil-
dren with primary speech and language 
disability. The results suggested that therapy 
was effective for children with vocabulary 
and phonological difficulties. However, the 
findings were heterogeneous, and it was 
concluded that more clinical trials were 
needed to prove the effectiveness of speech 
and language therapy among children with 
receptive language disorders.12
The production of speech, language and 
communicative gestures is usually affected by 
cerebral palsy. Those responsible for children 
with cerebral palsy make use of speech and 
language therapy to improve these children’s 
interactions with the world that surrounds 
them, and if possible make them a little more 
independent in their environment. Thus, Pen-
nington et al. (2004) analyzed the effectiveness 
of speech and language therapy among chil-
dren with cerebral palsy with communication 
disorders. There was no hard evidence for any 
positive effects from speech and language 
therapy on children with cerebral palsy. It was 
concluded that rigorous research needed to be 
carried out to confirm the link between speech 
and language therapy and improvement in 
communication in these children.13 
Apraxia is a neuropsychological disorder 
that can affect patients who have suffered 
a cardiovascular accident. It can be defined 
as a disorder that affects how articular move-
ments are performed, because of a lesion in 
the area responsible for programming, plan-
ning and executing the muscle movements 
needed to produce words. West et al. (2005) 
assessed whether therapeutic interventions 
improve functional speech in stroke patients 
with apraxia of speech, and which individual 
therapeutic interventions are effective. No 
trials were identified. There was no evidence 
from randomized trials to support or refute 
the effectiveness of therapeutic interventions 
for apraxia of speech. It was concluded that 
there was a need for high-quality randomized 
trials to be undertaken in this field.14
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We likewise retrieved a systematic review 
that had the purpose of analyzing the effec-
tiveness of neonatal hearing screening and 
early treatment programs for hearing loss. All 
neonates were screened, as well as children 
and adults with congenital bilateral hearing 
loss with a threshold of more than 40 dB. The 
long-term effectiveness of universal newborn 
hearing screening programs has not been es-
tablished to date. It was concluded that there 
was a need for controlled trials and before and 
after studies to address this issue further.15
El Dib et al. (2005) summarized the 
evidence regarding whether interventions for 
encouraging the wearing of hearing protection 
among workers exposed to noise in the work-
place were effective. Two studies were found. 
The authors concluded there was limited 
evidence available and that this did not show 
whether tailored interventions were more or 
less effective than general interventions among 
such workers, considering that 80% of them 
already use hearing protection. Long-lasting 
school-based interventions might increase the 
use of hearing protection substantially. These 
results were based on single studies only. 
It was concluded that better interventions 
for increasing the use of hearing protection 
needed to be developed and evaluated in order 
to increase the prevention of noise induced 
hearing loss among workers.16
Butler et al. (2003) assessed the evidence 
from randomized controlled trials regarding 
the effectiveness of screening and treating 
children with clinically significant otitis 
media with effusion (OME) during the 
first four years of their lives, in relation to 
language and behavioral outcomes. The au-
thors concluded that the randomized trials 
identified did not show that there was any 
significant benefit gained from screening 
the general population of asymptomatic 
children during their first four years of life 
for OME, in relation to language develop-
ment and behavior.17 
After reviewing the literature on speech, 
language and hearing therapy in the system-
atic review database, we also looked at the 
Cochrane central register of controlled tri-
als (CENTRAL) and located 1,384 clinical 
trials (out of a total of 435,786) that were 
potentially related to speech, language and 
hearing therapy, using the same terms men-
tioned earlier. These were also cross-checked 
through Boolean logical operators. These 
studies need critical appraisal to evaluate their 
scientific quality before their incorporation 
into practice.
CONCLUSIONS
We were able to identify 15 reviews in the 
Cochrane Library, of which two were protocols 
and 13 were complete systematic reviews.
It should be noted that, in all the sys-
tematic reviews described above, the authors 
were unable to provide fundamental practical 
implications that could act as guidelines for 
speech and language therapy and consequently 
reduce the therapeutic uncertainty. On the 
contrary, the authors’ findings were not con-
clusive enough to be included as interventions 
in clinical practice. In other words, there was 
not enough evidence available to establish 
what effect speech and language therapy has 
in diverse clinical situations. The best evi-
dence found was not good enough to detect 
a statistically significant difference in favor of 
such treatment, because of the small number 
of studies in the field of speech, language and 
hearing therapy that were carried out in a 
methodologically adequate fashion, and with 
acceptable sample size.
However, the authors were able to highlight 
the implications for research, and suggested that 
new well-designed and well-planned controlled 
clinical trials with larger numbers of partici-
pants should be conducted. 
Because systematic reviews have a 
commitment towards updating scientific 
knowledge, authors will be obliged to include 
such new methodologically acceptable and 
homogeneous clinical trials in their system-
atic reviews, as they are reported. It will be 
thus possible to add them to meta-analyses 
and, in so doing, to obtain scientific proof 
that speech and language therapy works, 
which is essential for the clinical situations 
discussed in this article, as well as for other 
communication disorders.
We know how necessary speech and lan-
guage therapy is for individuals to succeed in 
honing their communication skills, as well as 
for acquiring adequate neurovegetative function 
and developing the phonoarticulatory organs, to 
mention only two aspects of hearing loss preven-
tion. However, clinical evidence that one inter-
vention is better than another allows us to refine 
clinical practice, as we seek new alternatives to 
hasten patients’ progress and recovery.
Even when we really know that one type of 
treatment is effective, we should assess which 
approach is most effective among the possible 
interventions. In such cases it is important to 
develop new clinical trials. Clinical evidence 
that one intervention is better than another 
allows us to improve clinical practice and to 
search for new alternatives for developing and 
improving patient care. 
As mentioned earlier, the Cochrane 
Library also includes a database of clinical 
trials on therapeutic and prophylactic inter-
ventions. Any professional interested in these 
may identify many clinical trials relating to 
evidence-based speech, language and hearing 
therapy practice, in order to develop new 
systematic reviews and better clinical trials, 
thereby implementing the use of science in 
this very important field.
The amount of scientific information 
available regarding speech, language and 
hearing therapy does not support the belief 
obtained from practical experience that these 
techniques are useful.
Colleagues who are interested in this 
subject may obtain further information from 
the Cochrane Center site at http://www.
centrocochranedobrasil.org.br
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